CRISPR-KOALA Uncovers 81 New Genes Driving Basal-Like Triple-Negative Breast Cancer, Opening New Avenues for Targeted Treatments
Using a new gene editing tool called CRISPR KOALA, researchers at the Lunenfeld Tanenbaum Research Institute (Sinai Health, Toronto) identified 81 previously unknown genes that drive basal like triple negative breast... CRISPR KOALA overcomes a major limitation of standard CRISPR screening by being able to both acti...
Published byEdited with DeepSeek-V4-FlashImages generated with GPT Image 1.5
Using a new gene editing tool called CRISPR KOALA, researchers at the Lunenfeld Tanenbaum Research Institute (Sinai Health, Toronto) identified 81 previously unknown genes that drive basal like triple negative breast...
CRISPR KOALA overcomes a major limitation of standard CRISPR screening by being able to both activate and silence genes within the same animal model, allowing researchers to systematically test thousands of genes in l...
The team screened over 3,700 genes and found that 90% of the 81 cancer promoting genes had been completely missed by prior large scale cancer genomics studies.
Search & fact-check with cited sources for What did a team of scientists at Sinai Health in Toronto discover about basal-like triple-negativAn artistic representation of CRISPR gene editing. The new CRISPR-KOALA tool can simultaneously activate and silence genes in living animal models.
AI Prompt
Create a landscape editorial hero image for this Studio Global article: Search & fact-check with cited sources for What did a team of scientists at Sinai Health in Toronto discover about basal-like triple-negativ. Article summary: A team of scientists at the Lunenfeld-Tanenbaum Research Institute, part of Sinai Health in Toronto, developed a new gene-editing tool called **CRISPR-KOALA** and used it to identify **81 previously unknown genes that dr. Topic tags: general, government, academic, general web, user generated. Style: premium digital editorial illustration, source-backed research mood, clean composition, high detail, modern web publication hero. Use reference image context only for broad subject, composition, and topical grounding; do not copy the exact image. Avoid: logos, brand marks, copyrighted characters, real person likenesses, fake screenshots, UI text, readable text, wate
openai.com
A team of scientists at the Lunenfeld-Tanenbaum Research Institute, part of Sinai Health in Toronto, has developed a powerful new gene-editing tool called CRISPR-KOALA and used it to identify 81 previously unknown genes that drive basal-like triple-negative breast cancer (TNBC). The breakthrough was published in the journal Nature around July 2026, and it represents a major step forward in understanding and potentially treating one of the most aggressive forms of breast cancer .
Studio Global AI
Continue your research
This page includes a source-backed answer you can continue inside Studio Global.
What is the short answer to "CRISPR-KOALA Uncovers 81 New Genes Driving Basal-Like Triple-Negative Breast Cancer, Opening New Avenues for Targeted Treatments"?
Using a new gene editing tool called CRISPR KOALA, researchers at the Lunenfeld Tanenbaum Research Institute (Sinai Health, Toronto) identified 81 previously unknown genes that drive basal like triple negative breast...
What are the key points to validate first?
Using a new gene editing tool called CRISPR KOALA, researchers at the Lunenfeld Tanenbaum Research Institute (Sinai Health, Toronto) identified 81 previously unknown genes that drive basal like triple negative breast... CRISPR KOALA overcomes a major limitation of standard CRISPR screening by being able to both activate and silence genes within the same animal model, allowing researchers to systematically test thousands of genes in l...
What should I do next in practice?
The team screened over 3,700 genes and found that 90% of the 81 cancer promoting genes had been completely missed by prior large scale cancer genomics studies.
Triple-negative breast cancer (TNBC) is a subtype of breast cancer that does not express the estrogen receptor (ER), progesterone receptor (PR), or the HER2 protein . The